Physician profile
Eric Knapp
NPI 1700090602
$6,501.33
in general payments reported to CMS, 2019-2025
9 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.81 · 2020: $97.81 · 2021: $3,426 · 2022: $803 · 2023: $1,945 · 2024: $22.52 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $970 · Food and Beverage: $780 · Gift: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $970.38 |
| Food and Beverage | $780.25 |
| Gift | $344.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,046.72 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $969.78 | 2020-2022 | |
| Novo Nordisk INC | $125.68 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Tela Bio, INC. | $124.24 | 2020-2022 | |
| Abbvie INC. | $112.05 | 2021 | |
| Heron Therapeutics, INC. | $61.14 | 2023 | Aponvie |
| Ethicon US, LLC | $36.55 | 2019-2025 | Echelon Endopath |
| Merck Sharp & Dohme LLC | $13.29 | 2019 | |
| Covidien Lp | $11.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Knapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.